These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Modulating caspase activity: beyond the active site. Murray J; Renslo AR Curr Opin Struct Biol; 2013 Dec; 23(6):812-9. PubMed ID: 24215810 [TBL] [Abstract][Full Text] [Related]
3. The structural basis of allosteric regulation in proteins. Laskowski RA; Gerick F; Thornton JM FEBS Lett; 2009 Jun; 583(11):1692-8. PubMed ID: 19303011 [TBL] [Abstract][Full Text] [Related]
4. Apoptosis and cancer: mutations within caspase genes. Ghavami S; Hashemi M; Ande SR; Yeganeh B; Xiao W; Eshraghi M; Bus CJ; Kadkhoda K; Wiechec E; Halayko AJ; Los M J Med Genet; 2009 Aug; 46(8):497-510. PubMed ID: 19505876 [TBL] [Abstract][Full Text] [Related]
5. Conformational restrictions in the active site of unliganded human caspase-3. Ni CZ; Li C; Wu JC; Spada AP; Ely KR J Mol Recognit; 2003; 16(3):121-4. PubMed ID: 12833566 [TBL] [Abstract][Full Text] [Related]
6. Apoptosis: why and how does it occur in biology? Ulukaya E; Acilan C; Yilmaz Y Cell Biochem Funct; 2011 Aug; 29(6):468-80. PubMed ID: 21773978 [TBL] [Abstract][Full Text] [Related]
7. Allosteric regulation of proteases. Hauske P; Ottmann C; Meltzer M; Ehrmann M; Kaiser M Chembiochem; 2008 Dec; 9(18):2920-8. PubMed ID: 19021141 [TBL] [Abstract][Full Text] [Related]
8. The potential for caspases in drug discovery. MacKenzie SH; Schipper JL; Clark AC Curr Opin Drug Discov Devel; 2010 Sep; 13(5):568-76. PubMed ID: 20812148 [TBL] [Abstract][Full Text] [Related]
9. Strategies for the identification of allosteric modulators of G-protein-coupled receptors. Burford NT; Watson J; Bertekap R; Alt A Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747 [TBL] [Abstract][Full Text] [Related]
11. Drug discovery and the human kinome: recent trends. Eglen R; Reisine T Pharmacol Ther; 2011 May; 130(2):144-56. PubMed ID: 21256157 [TBL] [Abstract][Full Text] [Related]
12. Study of caspase inhibitors for limiting death in mammalian cell culture. Sauerwald TM; Oyler GA; Betenbaugh MJ Biotechnol Bioeng; 2003 Feb; 81(3):329-40. PubMed ID: 12474256 [TBL] [Abstract][Full Text] [Related]
14. [Substances modifying the activity of caspases]. Bartl T; Zádníková P; Jiríkovská R; Marousková B; Benes L Ceska Slov Farm; 2008 Jan; 57(1):29-34. PubMed ID: 18383921 [TBL] [Abstract][Full Text] [Related]
15. [Caspases--a target for intervention in diseases which are still difficult to treat]. Benes L; Benesová M Ceska Slov Farm; 2004 Jan; 53(1):18-26. PubMed ID: 15065392 [TBL] [Abstract][Full Text] [Related]
16. [Regulation of caspase activity in apoptosis]. Martynova EA Bioorg Khim; 2003; 29(5):518-43. PubMed ID: 14601408 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of AIF-mediated caspase-independent programmed cell death. Lorenzo HK; Susin SA Drug Resist Updat; 2007 Dec; 10(6):235-55. PubMed ID: 18180198 [TBL] [Abstract][Full Text] [Related]
19. Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells. Jiang C; Wang Z; Ganther H; Lu J Cancer Res; 2001 Apr; 61(7):3062-70. PubMed ID: 11306488 [TBL] [Abstract][Full Text] [Related]
20. Peptides and peptide mimics as modulators of apoptotic pathways. Orzáez M; Gortat A; Mondragón L; Pérez-Payá E ChemMedChem; 2009 Feb; 4(2):146-60. PubMed ID: 19021159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]